{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:53:38Z","timestamp":1782777218636,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alstr\u00f6m syndrome (AS) is a recessively inherited genetic condition which is ultra-rare and extremely complex. Symptoms include retinal dystrophy, nystagmus, photophobia, hearing loss, obesity, insulin resistance, diabetes and cardiomyopathy. The condition is progressive, but it is important to note that not all the complications associated with AS occur in everyone affected. Symptoms can also present at different stages, making diagnosis difficult. There are currently 88 people diagnosed with AS in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this report is to raise awareness of the key symptoms of AS, in order to promote a faster and more effective diagnosis. This involves identification of individual or a combination of \u2018red flag\u2019 symptoms. Overall the findings should improve the patient experience, and their long-term health outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between August-October 2022 we conducted research into a sample of patients from the ASUK database. The process involved a combination of interviews with families, social care and education reviews. Interviews were semi-structured using open questions and a patient-centred approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen newly diagnosed patients were included in our sample. Only 24% of patients were diagnosed within one year following the onset of AS symptoms. Patients with visual impairment and cardiomyopathy were diagnosed much more quickly, either in infancy or early childhood. 41% of our research participants waited over 5 years for a diagnosis. Insufficient research and treatment advances can further impede the diagnostic process and limit access to therapies or clinical trials, ultimately impacting patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While we welcome these developments, our findings, and the evidence we have gathered in this report suggests that more needs to be done to improve the experiences of people receiving a diagnosis of AS. Obesity rapidly developing in infancy should be flagged as a key symptom to be aware of where AS is a possible diagnosis. Visual impairment (88%) in combination with cardiomyopathy (59%) is a frequent first presentation for patients with AS. Most patients (7\/17) are diagnosed many years after symptom onset (5\u201320 years).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03509-y","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T10:22:08Z","timestamp":1736158928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Alstr\u00f6m syndrome: the journey to diagnosis"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-1787","authenticated-orcid":false,"given":"Akshat","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Leeson-Beevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Loughery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"issue":"12","key":"3509_CR1","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/sj.ejhg.5201933","volume":"15","author":"JD Marshall","year":"2007","unstructured":"Marshall JD, Beck S, Maffei P, Naggert JK. Alstr\u00f6m Syndrome. Eur J Hum Genet. 2007;15(12):1193\u2013202.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"3509_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1365-2265.2004.01952.x","volume":"60","author":"RB Paisey","year":"2004","unstructured":"Paisey RB, Carey CM, Bower L, Marshall J, Taylor P, Maffei P, et al. Hypertriglyceridaemia in Alstr\u00f6m\u2019s syndrome: causes and associations in 37 cases. Clin Endocrinol (Oxf). 2004;60(2):228\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"3509_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ng867","volume":"31","author":"GB Collin","year":"2002","unstructured":"Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstr\u00f6m syndrome. Nat Genet. 2002;31(1):74\u20138.","journal-title":"Nat Genet"},{"issue":"4","key":"3509_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ymgme.2017.05.017","volume":"121","author":"A Brofferio","year":"2017","unstructured":"Brofferio A, Sachdev V, Hannoush H, Marshall JD, Naggert JK, Sidenko S, et al. Characteristics of cardiomyopathy in Alstr\u00f6m syndrome: prospective single-center data on 38 patients. Mol Genet Metab. 2017;121(4):336\u201343.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"3509_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13023-020-01468-8","volume":"15","author":"N Tahani","year":"2020","unstructured":"Tahani N, Maffei P, Dollfus H, Paisey R, Valverde D, Milan G, et al. Consensus clinical management guidelines for Alstr\u00f6m syndrome. Orphanet J Rare Dis. 2020;15(1):253.","journal-title":"Orphanet J Rare Dis"},{"key":"3509_CR6","doi-asserted-by":"crossref","unstructured":"Marshall JD, Maffei P, Beck S, Barrett TG, Paisey R, Naggert JK. Clinical utility gene card for: Alstr\u00f6m Syndrome - update 2013. Eur J Hum Genet [Internet]. 2013 Nov [cited 2024 Feb 3];21(11). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3798853\/","DOI":"10.1038\/ejhg.2013.61"},{"issue":"3","key":"3509_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12098-018-2807-9","volume":"86","author":"G Nerakh","year":"2019","unstructured":"Nerakh G, Ranganath P. Alstr\u00f6m Syndrome presenting as isolated dilated cardiomyopathy. Indian J Pediatr. 2019;86(3):296\u20138.","journal-title":"Indian J Pediatr"},{"issue":"4","key":"3509_CR8","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1111\/aos.13612","volume":"96","author":"F Nasser","year":"2018","unstructured":"Nasser F, Weisschuh N, Maffei P, Milan G, Heller C, Zrenner E, et al. Ophthalmic features of cone-rod dystrophy caused by pathogenic variants in the ALMS1 gene. Acta Ophthalmol (Copenh). 2018;96(4):e445\u201354.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"1","key":"3509_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/jpi.jpi_20_19","volume":"10","author":"MRF Aghdam","year":"2019","unstructured":"Aghdam MRF, Vodovnik A, Hameed RA. Role of Telemedicine in Multidisciplinary Team meetings. J Pathol Inf. 2019;10(1):35.","journal-title":"J Pathol Inf"},{"key":"3509_CR10","unstructured":"Kapadia D, Zhang J, Salway S, Nazroo J, Booth A. Ethnic inequalities in Healthcare: A Rapid Evidence Review."},{"key":"3509_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-015-0366-y","volume":"10","author":"S Van Groenendael","year":"2015","unstructured":"Van Groenendael S, Giacovazzi L, Davison F, Holtkemper O, Huang Z, Wang Q, et al. High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease. Orphanet J Rare Dis. 2015;10:149.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3509_CR12","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1038\/s41467-022-32908-7","volume":"13","author":"WL Macken","year":"2022","unstructured":"Macken WL, Falabella M, McKittrick C, Pizzamiglio C, Ellmers R, Eggleton K, et al. Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing. Nat Commun. 2022;13(1):6324.","journal-title":"Nat Commun"},{"issue":"7","key":"3509_CR13","doi-asserted-by":"publisher","first-page":"e100603","DOI":"10.1371\/journal.pone.0100603","volume":"9","author":"J Wen","year":"2014","unstructured":"Wen J, Schulman KA. Can Team-Based Care improve patient satisfaction? A systematic review of Randomized controlled trials. PLoS ONE. 2014;9(7):e100603.","journal-title":"PLoS ONE"},{"issue":"1","key":"3509_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12902-018-0315-6","volume":"18","author":"S Baig","year":"2018","unstructured":"Baig S, Veeranna V, Bolton S, Edwards N, Tomlinson JW, Manolopoulos K, et al. Treatment with PBI-4050 in patients with Alstr\u00f6m syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. BMC Endocr Disord. 2018;18(1):88.","journal-title":"BMC Endocr Disord"},{"key":"3509_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12913-018-3001-5","volume":"18","author":"C Jongen","year":"2018","unstructured":"Jongen C, McCalman J, Bainbridge R. Health workforce cultural competency interventions: a systematic scoping review. BMC Health Serv Res. 2018;18:232.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"3509_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","volume":"24","author":"Z Stark","year":"2023","unstructured":"Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24(11):755\u201366.","journal-title":"Nat Rev Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03509-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03509-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T11:03:46Z","timestamp":1736161426000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03509-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03509-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4650898\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was extensively reviewed with ethical approval and consent in place. ASUK are a charitable organisation that receive funding from NHS England to carry out such reports, and data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}